Cardiovascular Effectiveness of Sodium‐Glucose Cotransporter 2 Inhibitors and Glucagon‐Like Peptide‐1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure

Cardiovascular Effectiveness of Sodium‐Glucose Cotransporter 2 Inhibitors and Glucagon‐Like Peptide‐1 Receptor Agonists in Older Patients in Routine Clinical Care With or Without History of Atherosclerotic Cardiovascular Diseases or Heart Failure

Background Randomized trials demonstrate the cardioprotective effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RA). We evaluated their relative cardiovascular effectiveness in routine care populations with a broad spectrum of atheroscl...

Full description

Bibliographic Details
Main Authors: Phyo T. Htoo, John Buse, Matthew Cavender, Tiansheng Wang, Virginia Pate, Jess Edwards, Til Stürmer
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
glucagon‐like peptide‐1 receptor
heart failure
myocardial infarction
sodium‐glucose transporter 2 inhibitors
type 2 diabetes
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.022376

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.022376

Similar Items